Protagonist Therapeutics, Inc Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Protagonist Therapeutics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Protagonist Therapeutics, Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$676K.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Protagonist Therapeutics, Inc annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $0 -$1.31M -100% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.31M +$2M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$691K +$108K +13.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$799K -$799K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2018-03-07
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.